bpc-157 peptide human clinical trials β the most prescribed you've never seen in a trial. 30 total subjects. Zero RCTs. A Phase 1 that was registered, enrolled, and then quietly canceled with no π₯π Peptides are one of
Description
BPC-157 is not FDA-approved for any use
There are reports of increased VEGF (linked to better blood supply) and modulation of TGF1, a cytokine associated with follicle regression and androgendriven thinning [1]

Lets talk about it

These different mechanisms make sermorelin and BPC-157 complementary rather than competitive